Evidence map›Paper›PMID 30518137›Full record

ArticleInternational journal of molecular sciences2018

Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.

Vladimir Purvanov, Christoph Matti, Guerric P B Samson, Ilona Kindinger, Daniel F Legler

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Intact lymph node homing and CD8Frontiers in immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Does CCL19 act as a double-edged sword in cancer development?Clinical and experimental immunology · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Vladimir PurvanovBiotechnology Institute Thurgau (BITg) at the University of Konstanz, CH-8280 Kreuzlingen, Switzerland. vladimir.purvanov@bitg.ch.
Christoph MattiBiotechnology Institute Thurgau (BITg) at the University of Konstanz, CH-8280 Kreuzlingen, Switzerland. christoph.matti@bitg.ch.
Guerric P B SamsonBiotechnology Institute Thurgau (BITg) at the University of Konstanz, CH-8280 Kreuzlingen, Switzerland. guerric.samson@bitg.ch.
Ilona KindingerBiotechnology Institute Thurgau (BITg) at the University of Konstanz, CH-8280 Kreuzlingen, Switzerland. ilona.kindinger@bitg.ch.
Daniel F LeglerBiotechnology Institute Thurgau (BITg) at the University of Konstanz, CH-8280 Kreuzlingen, Switzerland. daniel.legler@bitg.ch.ORCID 0000-0001-8610-4764
Biotechnology Institute Thurgau · CHUniversity of Konstanz · DE

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 31003A_169936Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung CRSII3_160719Staatssekretariat für Bildung, Forschung und Innovation BITgThurgauische Stiftung für Wissenschaft und Forschung BITg
6 · The paper itself

Abstract

Chemokines are essential guidance cues orchestrating cell migration in health and disease. Cognate chemokine receptors sense chemokine gradients over short distances to coordinate directional cell locomotion. The chemokines CCL19 and CCL21 are essential for recruiting CCR7-expressing dendritic cells bearing pathogen-derived antigens and lymphocytes to lymph nodes, where the two cell types meet to launch an adaptive immune response against the invading pathogen. CCR7-expressing cancer cells are also recruited by CCL19 and CCL21 to metastasize in lymphoid organs. In contrast, atypical chemokine receptors (ACKRs) do not transmit signals required for cell locomotion but scavenge chemokines. ACKR4 is crucial for internalizing and degrading CCL19 and CCL21 to establish local gradients, which are sensed by CCR7-expressing cells. Here, we describe the production of fluorescently tagged chemokines by fusing CCL19 and CCL21 to monomeric red fluorescent protein (mRFP). We show that purified CCL19-mRFP and CCL21-mRFP are versatile and powerful tools to study CCR7 and ACKR4 functions, such as receptor trafficking and chemokine scavenging, in a spatiotemporal fashion. We demonstrate that fluorescently tagged CCL19 and CCL21 permit the visualization and quantification of chemokine gradients in real time, while CCR7-expressing leukocytes and cancer cells sense the guidance cues and migrate along the chemokine gradients.

Indexed as

AnimalsCell MovementChemokine CCL19Chemokine CCL21CollagenDendritic CellsFluorescent DyesHEK293 CellsHumansMiceReceptors, CCRReceptors, CCR7Time-Lapse ImagingACKR4 protein, humanCCL19 protein, humanCCL21 protein, humanCCR7 protein, humanChemokine CCL19Chemokine CCL21CollagenFluorescent DyesReceptors, CCRReceptors, CCR7ACKR4cancer metastasisCCL19CCL21CCR7cell migrationchemokine receptorsfluorescent chemokinesleukocytes

Identifiers

PMID30518137
PMCPMC6321256
OpenAlexW2902066933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.